Assignee
AFFIRIS AG
AT·15 granted patents·12 pending applications·8 citations·filing 2009–2020
Top patents by PatentIndex Score
27 records- 0176US10646565B2Treatment of alzheimer'S disease (AD) with an aluminum saltAFFIRIS AG·Filed 2015·Granted May 12, 2020·1 cites·19 claims
- 0275US11065273B2Treatment and prevention of alzheimer's disease (AD)AFFIRIS AG·Filed 2015·Granted Jul 20, 2021·1 cites·15 claims
- 0374US10053518B2Substances and methods for the use in prevention and/or treatment in Huntington's diseaseAFFIRIS AG·Filed 2015·Granted Aug 21, 2018·2 cites·9 claims
- 0470US10517935B2Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disordersAFFIRIS AG·Filed 2016·Granted Dec 31, 2019·1 cites·10 claims
- 0570US10406197B2Substances and methods for the use in prevention and/or treatment in Huntington's diseaseAFFIRIS AG·Filed 2015·Granted Sep 10, 2019·2 cites·6 claims
- 0666US10933123B2Peptide vaccines usable for hypercholesterolemia related diseasesAFFIRIS AG·Filed 2018·Granted Mar 2, 2021·0 cites·10 claims
- 0766US2021040236A1Substances and methods for the use in prevention and/or treatment in huntington's diseaseAFFIRIS AG·Filed 2020·Application pending·0 cites
- 0864US9625459B2Method for diagnosing alzheimer's disease (AD)AFFIRIS AG·Filed 2012·Granted Apr 18, 2017·1 cites·18 claims
- 0960US2018327513A1Substances and methods for the use in prevention and/or treatment in huntington's diseaseAFFIRIS AG·Filed 2018·Application pending·0 cites
- 1060US2011092436A1Compounds for treating symptoms associated with parkinson's diseaseAFFIRIS AG·Filed 2009·Application pending·0 cites
- 1159US9533030B2Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivoAFFIRIS AG·Filed 2013·Granted Jan 3, 2017·0 cites·11 claims
- 1255US9999659B2Treatments using a peptide and/or vaccineAFFIRIS AG·Filed 2016·Granted Jun 19, 2018·0 cites·19 claims
- 1353US2015093432A1CompositionAFFIRIS AG·Filed 2013·Application pending·0 cites
- 1452US10576131B2IL-23-p19 vaccinesAFFIRIS AG·Filed 2016·Granted Mar 3, 2020·0 cites·13 claims
- 1552US9964547B2Method for detecting aSyn-specific antibodies in a biological sampleAFFIRIS AG·Filed 2014·Granted May 8, 2018·0 cites·19 claims
- 1651US2016008443A1METHOD FOR TREATING A beta-AMYLOIDOSISAFFIRIS AG·Filed 2015·Application pending·0 cites
- 1750US2015093431A1CompositionsAFFIRIS AG·Filed 2013·Application pending·0 cites
- 1845US2014179900A1Treatment of atherosclerosis with cholesterol ester transport protein mimotopesAFFIRIS AG·Filed 2013·Application pending·0 cites
- 1944US2020016249A1Il-23-p19 vaccinesAFFIRIS AG·Filed 2019·Application pending·0 cites
- 2043US9669079B2PCSK9 peptide combination vaccine and method of useAFFIRIS AG·Filed 2015·Granted Jun 6, 2017·0 cites·20 claims
- 2142US2015306194A1Method for treating a synucleiopathyAFFIRIS AG·Filed 2015·Application pending·0 cites
- 2241US10478454B2Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxideAFFIRIS AG·Filed 2015·Granted Nov 19, 2019·0 cites·12 claims
- 2339US10344062B2Method of inhibiting C5aAFFIRIS AG·Filed 2013·Granted Jul 9, 2019·0 cites·21 claims
- 2437US10004791B2Peptide vaccines against PCSK9AFFIRIS AG·Filed 2015·Granted Jun 26, 2018·0 cites·17 claims
- 2533US2019127438A1Alpha chain of the high-affinity ige receptor (fceria)AFFIRIS AG·Filed 2017·Application pending·0 cites
- 2632US2018186896A1Vaccines for the treatment and prevention of ige mediated diseasesAFFIRIS AG·Filed 2016·Application pending·0 cites
- 2725US2017137509A1Vaccines and monoclonal antibodies targeting truncated variants of osteopontin and uses thereofAFFIRIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AFFIRIS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →